| Vor Biopharma Inc. (VOR) |
| Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 |
| Balance Sheet Date | | | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fiscal Period | | | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Common Stock | 15.87$ | 17.83$ | 13.09$ | 48.58$ | 1.61$ | 0.72$ | 1.11$ | 0.69$ | 1.03$ | 2.36$ | 2.22$ | 2.12$ | 3.07$ | 5.38$ | 6.62$ | 3.93$ | 5.05$ | 5.97$ | 11.67$ | 15.71$ | 18.68$ | 43.12$ | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Market Cap of Common Stock | 775,209,888$ | 870,950,996$ | 136,275,147$ | 6,154,265,532$ | 201,184,827$ | 89,943,054$ | 75,884,341$ | 47,427,746$ | 70,307,390$ | 160,537,456$ | 150,528,625$ | 142,844,308$ | 205,222,592$ | 357,090,958$ | 255,969,966$ | 149,561,283$ | 189,871,673$ | 223,805,569$ | 435,168,512$ | 583,541,148$ | 693,618,904$ | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| QoQ% | (10.99%) | 539.11% | (97.79%) | 2,959.01% | 123.68% | 18.53% | 60.00% | (32.54%) | (56.21%) | 6.65% | 5.38% | (30.40%) | (42.53%) | 39.51% | 71.15% | (21.23%) | (15.16%) | (48.57%) | (25.43%) | (15.87%) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| YoY% | 285.32% | 868.34% | 79.58% | 12,876.09% | 186.15% | (43.97%) | (49.59%) | (66.80%) | (65.74%) | (55.04%) | (41.19%) | (4.49%) | 8.09% | 59.55% | (41.18%) | (74.37%) | (72.63%) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Warrant | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Unit | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Right | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Shares Outstanding | | 48,847,504 | 38,720,196 | 9,026,922 | 6,282,289 | 6,242,568 | 6,238,799 | 3,433,273 | 3,418,143 | 3,411,166 | 3,395,072 | 67,785,469 | 67,433,560 | 66,934,897 | 65,996,138 | 38,393,211 | 37,506,236 | 37,336,314 | 37,174,741 | 37,018,282 | 36,885,372 | 36,770,010 | 505,074 | 277,724 | 165,310 | 151,320 | | | | | | | | | | | | | | | | | | | | | | | |
| QoQ% | | 26.16% | 328.94% | 43.69% | .64% | .06% | 81.72% | .44% | .21% | .47% | (94.99%) | .52% | .75% | 1.42% | 71.90% | 2.37% | .46% | .44% | .42% | .36% | .31% | 7,180.12% | 81.86% | 68.00% | 9.25% | | | | | | | | | | | | | | | | | | | | | | | | |
| YoY% | | 682.49% | 520.64% | 162.93% | 83.79% | 83.00% | 83.76% | (94.94%) | (94.93%) | (94.90%) | (94.86%) | 76.56% | 79.79% | 79.28% | 77.53% | 3.71% | 1.68% | 1.54% | 7,260.26% | 13,229.16% | 22,212.85% | 24,199.50% | | | | | | | | | | | | | | | | | | | | | | | | | | | |